Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Applications of 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide in preparation of neurological disease treatment products

A use, a technology for Alzheimer's disease, applied in the field of application of 5-(3,4-methylenedioxyphenyl)-2E,4E pentadienoic acid n-propylamine amide in the preparation of products for the treatment of neurological diseases , can solve the problem of serious side effects

Active Publication Date: 2014-09-17
GENERAL HOSPITAL OF PLA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Also, antipsychotic treatment may be associated with serious side effects such as tardive dyskinesia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Applications of 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide in preparation of neurological disease treatment products
  • Applications of 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide in preparation of neurological disease treatment products
  • Applications of 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide in preparation of neurological disease treatment products

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1: 5-(3,4-methylenedioxyphenyl)-2E, 4E pentadienoic acid n-propanamine amide has monoamine oxidase inhibitory activity

[0022] 1. Materials:

[0023] 1.1 Animals: Wisteria rats, provided by the Animal Center of the Academy of Military Medical Sciences, certificate number: SCXK-(Army) 2002-001.

[0024] 1.2 Medicines and Reagents Piperine (purchased from Beijing Pharmaceutical Purchasing and Supply Station), with a purity of 98%. Thin-layer chromatography silica gel H (chemically pure, purchased from Qingdao Ocean Chemical Co., Ltd.); column chromatography silica gel (reagent grade, 200-300 mesh, purchased from Qingdao Ocean Chemical Co., Ltd.); thin-layer chromatography silica gel prefabricated plate (purchased Yantai Institute of Chemical Industry); PBS phosphate buffer (purchased from Beijing Solarbio); MAO-A inhibitor clorgyline, MAO-B inhibitor selegiline, MAO enzyme reaction substrate kynuramine dihydrobromide, standard 4-hydroxy quinoline (purchased fro...

Embodiment 2

[0042] Example 2: Research on antidepressant activity of 5-(3,4-methylenedioxyphenyl)-2E, 4E pentadienoic acid n-propylamine amide

[0043] 1. Materials:

[0044] 1.1 Animals 120 SPF grade Kunming mice (18-22g), all male.

[0045] 1.2 Medicines and reagents piperine (Beijing Pharmaceutical Purchasing and Supply Station), with a purity of 98%. DMEM / F12 (1:1) medium (Hyclone Company); thiazolium blue (Merck Company); desipramine (purchased from Sigma Company); corticosterone (Sigma Company); fetal bovine serum (Hangzhou Sijiqing Bioengineering Materials Co., Ltd.); PBS (Beijing Solarbio Company); dimethyl sulfoxide (Beijing Chemical Reagent Company, batch number 060730); thionyl chloride (Beijing Chemical Reagent Company); sulfuric acid (Beijing Chemical Reagent Company); hydrochloric acid (Beijing Chemical Reagent Company); Reagent Company); trypsin (Beijing Trypsin Amresco0458 subpackage); penicillin, streptomycin (North China Pharmaceutical Co., Ltd.). Potassium hydroxide ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to uses of 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide in preparation of medicinal compositions for treatment and / or prevention of neuron diseases requiring neuroprotection effects and / or nerve regeneration. The 5-(3,4-methylenedioxy phenyl)-2E,4E pentadienoic acid propylamine amide provides good treatment effects for depressions caused by various causes, provides significant anti-depression activity for a pharmacological depression model, provides a good protection effect for SH-SY5Y cells damaged by glutamic acid, and provides a selective inhibition effect for monoamine oxidase B (MAO-B).

Description

technical field [0001] The present invention relates to the application of 5-(3,4-methylenedioxyphenyl)-2E,4E n-propanylamine pentadienate in the preparation of products for treating and / or preventing neurological and / or psychiatric diseases. technical background [0002] Neurological disorders are medical conditions that include diseases or disorders that affect the nervous system. A neurological disorder may be pathological damage to the nervous system associated with a disease or disorder, or an improvement in neurological function to improve learning and memory in order to improve cognitive abilities. [0003] With the aging population, Alzheimer's disease (also known as Alzheimer's disease, hereinafter referred to as AD) has become a social problem that seriously endangers human health. The horror of this disease lies in its wide-ranging implications, because in addition to the severe loss of memory and cognitive ability of the patient himself, it will also bring heavy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/36A61P25/28A61P25/24A61P25/00A61P25/18
Inventor 刘屏穆丽华胡园郭代红杨洁郭绍来
Owner GENERAL HOSPITAL OF PLA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com